PBS listing expanded to include treatment resistant high frequency episodic migraine

31 October 2023 - From 1 November 2023, Australians with treatment resistant high frequency episodic migraine will have access to fremanezumab ...

Read more →

Fresh hope over discontinued painkiller but patients fear replacement doses are 'useless'

27 October 2023 - Patients with terminal illnesses and painful chronic conditions have been offered hope thanks to a deal ...

Read more →

Updates to the HTA Review Research and analysis papers collection: draft HTA expert paper published (30 October 2023)

30 October 2023 - The draft paper International Health Technology Market Approval, Funding and Assessment Pathways developed to support the ...

Read more →

Expanded access to chronic heart failure treatment on the PBS

30 October 2023 - More Australians with chronic heart failure will have access to subsidised treatment under the PBS. ...

Read more →

Updated agenda for November 2023 PBAC meeting (30 October 2023)

30 October 2023 - The agenda for this week's November 2023 meeting has been updated. ...

Read more →

Expressions of interest to join the Pharmaceutical Benefits Remuneration Tribunal

30 October 2023 - The Department of Health is seeking expressions of interest to fill three vacancies on the Pharmaceutical ...

Read more →

100,000 patients eligible for heart drug under PBS

28 October 2023 - Almost 100,000 patients are set to save hundreds of dollars per year as access to a ...

Read more →

Public Summary Documents – July 2023 PBAC meeting

27 October 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2023 PBAC ...

Read more →

Updates to the HTA Policy and Methods Review Reference Committee (23 October 2023)

23 October 2023 - Two more documents from the review are now available. ...

Read more →

Life changing gene therapy for babies with spinal muscular atrophy

23 October 2023 - The Australian Government is giving more families access to life changing gene therapy for spinal muscular atrophy ...

Read more →

1 November 2023 changes to the PBS listings of medicines for severe active rheumatoid arthritis

23 October 2023 - On 1 November 2023, changes will be made to the authority requirements of the following biological ...

Read more →

1 November 2023 changes to the PBS listings of medicines for children and adolescents with chronic plaque psoriasis

23 October 2023 - On 1 November 2023, changes will be made to the authority requirements of the PBS listing ...

Read more →

Cheaper medicines for cervical cancer, urotherial cancer and spinal muscular atrophy

16 October 2023 - From 1 October 2023, Australians with cervical cancer, urothelial cancer and spinal muscular atrophy will have access ...

Read more →

Outcomes of the September 2023 PBAC intracycle meeting

13 October 2023 - The outcomes from the September 2023 PBAC intracycle meeting are now available. ...

Read more →

Updates to the HTA Policy and Methods Review Reference Committee (October 2023)

11 October 2023 - The draft paper Horizon Scanning and Early Assessment developed to support the deliberations of the HTA ...

Read more →